Marie-Therese Dimanche-Boitrel
Overview
Explore the profile of Marie-Therese Dimanche-Boitrel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
790
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kara-Ali G, Cano L, Dion S, Imerzoukene G, Hamon A, Simoes Eugenio M, et al.
Int J Cancer
. 2024 Feb;
154(11):1999-2013.
PMID: 38308587
The global pandemic of metabolic diseases has increased the incidence of hepatocellular carcinoma (HCC) in the context of non-alcoholic steatohepatitis (NASH). The downregulation of the E3 ubiquitin ligase TRIM21 has...
2.
Pelletier R, Gicquel T, Simoes Eugenio M, Ferron P, Morel I, Delehouze C, et al.
Pharmaceutics
. 2022 Dec;
14(12).
PMID: 36559159
Sibiriline is a novel drug inhibiting receptor-interacting protein 1 kinase (RIPK1) and necroptosis, a regulated form of cell death involved in several disease models. In this study, we aimed to...
3.
Hameed H, Farooq M, Vuillier C, Piquet-Pellorce C, Hamon A, Dimanche-Boitrel M, et al.
Int J Mol Sci
. 2022 Jul;
23(13).
PMID: 35806372
Some life-threatening acute hepatitis originates from drug-induced liver injury (DILI). Carbon tetrachloride (CCl)-induced acute liver injury in mice is the widely used model of choice to study acute DILI, which...
4.
Farooq M, Simoes Eugenio M, Piquet-Pellorce C, Dion S, Raguenes-Nicol C, Santamaria K, et al.
J Mol Med (Berl)
. 2022 Apr;
100(7):1027-1038.
PMID: 35476028
Non-alcoholic steatohepatitis (NASH), a chronic liver disease that emerged in industrialized countries, can further progress into liver fibrosis, cirrhosis, and hepatocellular carcinoma. In the next decade, NASH is predicted to...
5.
Delehouze C, Comte A, Leon-Icaza S, Cougoule C, Hauteville M, Goekjian P, et al.
Sci Rep
. 2022 Mar;
12(1):5118.
PMID: 35332201
Nigratine (also known as 6E11), a flavanone derivative of a plant natural product, was characterized as highly specific non-ATP competitive inhibitor of RIPK1 kinase, one of the key components of...
6.
Farooq M, Hameed H, Dimanche-Boitrel M, Piquet-Pellorce C, Samson M, Le Seyec J
Nutrients
. 2022 Jan;
14(2).
PMID: 35057565
The globally prevalent disease, non-alcoholic steatohepatitis (NASH), is characterized by a steatotic and inflammatory liver. In NASH patients, tissue repair mechanisms, activated by the presence of chronic liver damage, lead...
7.
Ahmadu A, Delehouze C, Haruna A, Mustapha L, Lawal B, Udobre A, et al.
Molecules
. 2021 Aug;
26(15).
PMID: 34361750
The purpose of this work is to investigate the protein kinase inhibitory activity of constituents from stem bark. Column chromatography and NMR spectroscopy were used to purify and characterize betulin...
8.
Simoes Eugenio M, Faurez F, Kara-Ali G, Lagarrigue M, Uhart P, Bonnet M, et al.
Front Mol Biosci
. 2021 May;
8:645134.
PMID: 33937329
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a well-known apoptosis inducer and a potential anticancer agent. When caspases and inhibitors of apoptosis proteins (IAPs) are inhibited, TRAIL induces necroptosis. Molecular...
9.
Intrahepatocytic necroptosis is dispensable for hepatocyte death in murine immune-mediated hepatitis
Hamon A, Piquet-Pellorce C, Dimanche-Boitrel M, Samson M, Le Seyec J
J Hepatol
. 2020 Jun;
73(3):699-701.
PMID: 32586641
No abstract available.
10.
Simoes Eugenio M, Farooq M, Dion S, Devisme C, Raguenes-Nicol C, Piquet-Pellorce C, et al.
Cancers (Basel)
. 2020 Jun;
12(6).
PMID: 32521615
The increase of the sedentary lifestyle and high-calorie diet have modified the etiological landscape of hepatocellular carcinoma (HCC), with a recrudescence of non-alcoholic fatty liver disease (NAFLD), especially in Western...